The three largest US drug distributors and a major generic-drug manufacturer have agreed to pay more than $250m (€225m) to settle the first federal trial over the companies’ role in fuelling the US opioid epidemic.

Bayer is understood to be proposing to pay as much as $8bn (€7.1bn) to settle more than 18,000 US lawsuits alleging its Roundup herbicide causes cancer.